Approval of the world's first nasal corona vaccine: Made by Bharat Biotech to be used as a booster dose

The Government of India has approved the world's first nasal corona vaccine. Hyderabad-based Bharat Biotech, which manufactures Covaxin, has developed it in collaboration with the Washington University School of Medicine (WUSM). This vaccine taken from the nose can be applied as a booster dose.

First of all, the nasal vaccine will be made available in private hospitals, for which people will have to pay. According to the news agency, it has been included in the Corona vaccination program since today itself. This nasal vaccine of Bharat Biotech has been named iNCOVACC. Earlier it was named BBV154. It will be delivered to the body through the nose.

Its special thing is that it blocks both infection and transmission of corona as soon as it enters the body. This vaccine does not require injection, so there is no risk of injury. Also, healthcare workers will not need special training.

At present, we are being vaccinated through injection into the muscles. This vaccine is called an intramuscular vaccine. A nasal vaccine is one that is given through the nose. Because it is given through the nose, it is called an intranasal vaccine. That is, it does not need to be given by injection, nor is it administered like an oral vaccine. It's kind of like a nasal spray.